R-Pharm Spotlight Research - Aiding the public, in sickness and health
R-Pharm is one of the largest private pharmaceutical companies in Russia and one of the leading suppliers to the public procurement segmentThe company is involved in all the stages of pharmaceutical industry value chain and partners with world-leading pharmaceutical companies
H1 21 revenues increased by 21% yoy driven by sales of innovative products. FCF turned positive on WC improvements despite rising capex yoy
The company's shares are currently not listed
The Institutional Equity Research team of Raiffeisen Bank International AG covers 85 stocks from Austria, Central & Eastern Europe with sell-side research and thus levers our local broker status with excellent company relationships. For corporates in Austria, CEE and Western Europe, we offer co-sponsored research, which includes research coverage and marketing activities to investors. Additionally, through our Spotlight Research product we also shed light on leading European small and micro-caps, seeking greater visibility with investors.
The Institutional Equity Research team consists of roughly 15 analysts, both in Vienna and the CEE countries. Our analysts provide long-standing sector expertise in tandem with profound local market know how and a sectoral approach across the entire region.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.